Alector (ALEC) Current Assets (2018 - 2026)
Alector (ALEC) posted quarterly Current Assets of $215.1 million for Q1 2026, down 41.34% year-over-year from $366.6 million in Q1 2025, and down 19.28% quarter-over-quarter from $266.5 million in Q4 2025.
Alector (ALEC) Current Assets (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Current Assets for 9 consecutive years, with $215.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 41.34% year-over-year to $215.1 million; the TTM figure through Mar 2026 stood at $215.1 million (down 41.34% YoY), while the FY2025 annual figure was $266.5 million, down 37.28% from the prior year.
- Current Assets retreated to $215.1 million in Q1 2026 per ALEC's latest filing, from $266.5 million in the prior quarter.
- Across five years, Current Assets topped out at $890.9 million in Q1 2022 and bottomed at $215.1 million in Q1 2026.
- Historically, Current Assets has averaged $540.9 million across 5 years, with a median of $565.8 million in 2023.
- Annual changes were most pronounced in 2022 — Current Assets soared 151.12% — and 2026, when it slumped 41.34%.
- Alector's Current Assets stood at $726.4 million in 2022, then retreated by 22.11% to $565.8 million in 2023, then dropped by 24.92% to $424.8 million in 2024, then sank by 37.28% to $266.5 million in 2025, then declined by 19.28% to $215.1 million in 2026.
- Business Quant data shows ALEC's Current Assets at $215.1 million in Q1 2026, $266.5 million in Q4 2025, and $300.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | 180.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 180.09 Mn |
| Mar 31, 2026 | 215.08 Mn |
| Dec 31, 2025 | 266.45 Mn |
| Sep 30, 2025 | 300.39 Mn |
| Jun 30, 2025 | 319.18 Mn |
| Mar 31, 2025 | 366.65 Mn |
| Dec 31, 2024 | 424.82 Mn |
| Sep 30, 2024 | 469.36 Mn |
| Jun 30, 2024 | 519.70 Mn |
| Mar 31, 2024 | 581.39 Mn |
| Dec 31, 2023 | 565.81 Mn |
| Sep 30, 2023 | 613.15 Mn |
| Jun 30, 2023 | 647.99 Mn |
| Mar 31, 2023 | 686.00 Mn |
| Dec 31, 2022 | 726.44 Mn |
| Sep 30, 2022 | 774.96 Mn |
| Jun 30, 2022 | 827.02 Mn |
| Mar 31, 2022 | 890.93 Mn |
| Dec 31, 2021 | 749.71 Mn |
| Sep 30, 2021 | 788.02 Mn |